↓ Skip to main content

Cochrane Database of Systematic Reviews

Interferon beta for secondary progressive multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
2 news outlets
blogs
2 blogs
policy
1 policy source
twitter
3 tweeters
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
134 Mendeley
Title
Interferon beta for secondary progressive multiple sclerosis
Published in
Cochrane database of systematic reviews, January 2012
DOI 10.1002/14651858.cd005181.pub3
Pubmed ID
Authors

Loredana La Mantia, Laura Vacchi, Carlo Di Pietrantonj, George Ebers, Marco Rovaris, Sten Fredrikson, Graziella Filippini

Abstract

Therapy with either recombinant beta-1a or beta-1b interferons (IFNs) is worldwide approved for Relapsing Remitting Multiple Sclerosis (RRMS). A major unanswered question is whether this treatment is able to safely reverse or retard the progressive phase of the disease.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 134 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 1%
Turkey 1 <1%
France 1 <1%
Unknown 130 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 17%
Student > Master 20 15%
Researcher 17 13%
Student > Bachelor 10 7%
Other 10 7%
Other 24 18%
Unknown 30 22%
Readers by discipline Count As %
Medicine and Dentistry 54 40%
Psychology 10 7%
Agricultural and Biological Sciences 6 4%
Social Sciences 6 4%
Neuroscience 6 4%
Other 16 12%
Unknown 36 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2022.
All research outputs
#1,006,427
of 23,342,232 outputs
Outputs from Cochrane database of systematic reviews
#2,220
of 12,632 outputs
Outputs of similar age
#6,745
of 248,633 outputs
Outputs of similar age from Cochrane database of systematic reviews
#26
of 234 outputs
Altmetric has tracked 23,342,232 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,632 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.9. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,633 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 234 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.